medigraphic.com
ISSN 1561-2988 (Impreso)

2016, Número 1

<< Anterior Siguiente >>

Rev Cubana Farm 2016; 50 (1)


Determinación analítica de sibutramina en productos para la pérdida de peso

Campos FJA, Jiménez HLG

Idioma: Español
Referencias bibliográficas: 46
Paginas: 151-161
Archivo PDF: 123.19 Kb.


RESUMEN

El sobrepeso y la obesidad son considerados un problema de salud pública a nivel mundial y a la postre, esa condición incentiva que millones de personas consuman productos para perder o controlar el peso. Dentro de este significativo mercado se puede encontrar una gran cantidad y variedad de productos que se comercializan con la denominación de origen natural. En la última década, se presenta que muchos de ellos son adulterados con sustancias sintéticas para potencializar su efecto. Una de las drogas sintéticas que se utiliza con ese propósito es la sibutramina, aun cuando fue retirada del mercado a nivel mundial en el año 2010 debido a sus graves efectos secundarios. En este trabajo se describen algunos ejemplos de casos importantes de adulteración de productos naturales en el orbe y las metodologías analíticas que se pueden utilizar en la determinación de su adulteración con sibutramina; luego de revisar y seleccionar artículos científicos de los últimos años y acceder a través de bases de datos Proquest, Scient Direct, Springer, EBSCO y otras del Sistema de Bibliotecas e Información de la Universidad de Costa Rica. Se encontró una variedad de técnicas y metodologías analíticas que permiten identificar y cuantificar la presencia de sibutramina en productos utilizados para bajar de peso.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Malik V, Willet W, Hu F. Global obesity: Trends, risk factors and policy implications. Nature Reviews: Endocrinology. 2013;9(1):13-27.

  2. Organización Mundial de la Salud. Obesidad y Sobrepeso May (2012) [citado 3 jun 2014]. Disponible en: http://www.who.int/mediacentre/factsheets/fs311/es/

  3. Finkelstein E, Khavjou O, Thompson H, Trogdon J, Pan L, Sherry B, et al. Obesity and severe obesity forecasts through 2030. American Journal of Preventive Medicine. 2012;42(6):563-70.

  4. Food and Drug Administration. Food Label Helps Consumers Make Healthier Choices. 2013. [citado 14 agosto 2015]. Disponible en: http://www.fda.gov/ForConsumers/ConsumerUpdates/ucm094536.htm

  5. Ariburnu E, Uludag M, Yalcinkaya H, Yesilada E. Comparative determination of sibutramine as an adulterant in natural slimming products by HPLC and HPTLC densitometry. Journal of Pharmaceutical and Biomedical Analysis. 2012;64-65:77- 81.

  6. Chen S, Tang M, Ng S, Poon W, Chan A, Mak T. Psychosis associated with usage of herbal slimming products adulterated with sibutramine: A case series. Clinical Toxicology. 2010;48(8):832-38.

  7. De Carvalho L, Martini M, Moreira A, de Lima A, Correia D, Falcão T. et al. Presence of synthetic pharmaceuticals as adulterants in slimming phytotherapeutic formulations and their analytical determination. Forensic Science International. 2011;204(1-3):6-12.

  8. Phattanawasin P, Sotanaphun U, Sukwattanasinit T, Akkarawaranthorn J, Kitchaiya S. Quantitative determination of sibutramine in adulterated herbal slimming formulations by TLC-image analysis method. Forensic Science International. 2012;219(1-3):96-100.

  9. Food and Drug Administration. Questions and Answers about FDA's Initiative against Contaminated Weight Loss Products. 2013 Sep [citado 3 jun 2014]. Disponible en: http://www.fda.gov/drugs/resourcesforyou/consumers/questionsanswers/ucm1361 87.htm

  10. Velázquez E. Retiro de la sibutramina: Un paso atrás en el tratamiento de la obesidad. Revista Venezolana de Endocrinología y Metabolismo. 2011;9(1):1-3.

  11. Chong C. Psychosis related to the use of sibutramine disguised as over-thecounter herbal weight loss remedies: A report of two patients. East Asian Archives of Psychiatr. 2010;20(4):186-9.

  12. Yuen Y, Lai C, Poon W, Ng S, Chan A, Mak T. Adulteration of over-the-counter slimming products with pharmaceutical analogues an emerging threat. Hong Kong Medical Journal. 2007;13(3):216-20.

  13. Pamo-Reyna O. El gran reto de la industria farmacéutica: Medicamentos eficaces y seguros. Revista de la Sociedad Peruana de Medicina Interna. 2011;24(1):3.

  14. Villalón G. Advertencia sobre isotretinoina y sibutramina. Evidencia: Actualización en la Práctica Ambulatoria. 2010;13(1):10.

  15. Food and Drug Administration. More Weight Loss Products Added to Consumer Alert. 2013. [citado 14 agosto 2014]. Disponible en: http://www.fda.gov/forconsumers/consumerupdates/ucm103184.htm

  16. Dégardin K, Roggo Y, Margo P. Forensic intelligence for medicine anticounterfeiting. Forensic Science International. 2015; 248:15-32.

  17. Li Y, Zhang H, Hu J, Xue F, Li Y, Sun C. A GC-EI-MS-MS method for the simultaneous determination of seven adulterants in slimming functional foods. Journal of Chromatographic Science. 2012;50(10):928-33.

  18. Song F, Monroe D, El-Demerdash A, Palmer C. Screening for multiple weight loss and related drugs in dietary supplement materials by flow injection tandem mass spectrometry and their confirmation by liquid chromatography tandem mass spectrometry. Journal of Pharmaceutical and Biomedical Analysis. 2014; 88:136-43.

  19. Jung J, Hermans-Claussen M, Weinmann W. Anoretic sibutramine detected in a Chinese herbal drug for weight loss. Forensic Science International. 2006; 161(2- 3):221-22.

  20. Huang Z, Xiao S, Luo D, Chen B, Yao S. Simultaneous determination of sibutramine and N-di-desmethylsibutramine in dietary supplements for weight control by HPLC-ESI-MS. Journal of Chromatographic Science. 2008;46(8):707-11.

  21. Kim S, Lee J, Yoon T, Choi J, Choi D, Kim D. et al. Simultaneous determination of anti-diabetes/anti-obesity drugs by LC/PDA, and targeted analysis of sibutramine analog in dietary supplements by LC/MS/MS. Biomedical Chromatography. 2009;23(12):1259-65.

  22. Shi Y, Sun C, Gao B, Sun A. Development of a liquid chromatography tandem mass spectrometry method for simultaneous determination of eight adulterants in slimming functional foods. Journal of Chromatography. 2011;1218(42):7655-62.

  23. Carvalho J, da Silva A, da Cunha A, Aucélio R, Alberti A, Leandro K. Voltammetric determination of sibutramine in beverages and in pharmaceutical formulations. Química Nova. 2012;35(5):988-92.

  24. Deconinck E, Verlinde K, Courselle P, De Beer J. A validated ultra high pressure liquid chromatographic method for the characterization of confiscated illegal slimming products containing anorexics. Journal of Pharmaceutical and Biomedical Analysis. 2012;59:38-43.

  25. Deconinck E, Sacré P, Courselle P, De Beer J. Chromatography in the Detection and Characterization of Illegal Pharmaceutical Preparations. Journal of Chromatographic Science. 2013;51(8):791-806.

  26. Bhatia L, Thumar K, Tanna R. Determination of adulteration of anti-obesity drug in Indian herbal medicinal product: Development and validation of analytical method. Inventi Impact: Pharm Analysis and Quality Assurance. 2012;(3):177-82.

  27. Khazan M, Hedayati M, Kobarfard F, Askari S, Azizi F. Identification and determination of synthetic pharmaceutical as adulterants in eight common herbal weight loss supplements. Iranian Red Crescent Medical Journal. 2014;16(3):1-6.

  28. Csupor D, Boros K, Dankó B, Veres K, Szendrei K, Hohmann J. Rapid identificaction of sibutramine in dietary supplements using a stepwise approach. Pharmazie. 2013;68(1):15-8.

  29. Ancuceanu R, Dinu M, Aramă C. Weight loss food supplements: Adulteration and multiple quality issues in two products of Chinese origin. Farmacia . 2013;61(6):28-44.

  30. Dunn J, Gryniewicz-Ruzicka C, Kauffman J, Westenberger B, Buhse L. Using a portable ion mobility spetrometer to screen dietary supplements for sibutramine. Journal of Pharmaceutical and Biomedical Analysis. 2011;54(3):469-74.

  31. De Carvalho L, Martini M, Moreira A, Garcia S, do Nascimento P, Bohrer D. Determination of synthetic pharmaceuticals in phytotherapeutics by capillary zone electrophoresis with contactless conductivity detection (CZE-C4D). Microchemical Journal. 2010;96(1):114-19.

  32. Stypułkowska K, Błażewicz A, Maurin J, Sarna K, Fijałek Z. X-ray power diffractometry and liquid chromatography studies of sibutramine and its analogues content in herbal dietary supplements. Journal of Pharmaceutical and Biomedical Analysis. 2011;56(5):969-75.

  33. Zou P, Oh S, Kiang K, Low M, Bloodworth B. Detection of sibutramine, its two metabolites and one analogue in a herbal product for weight loss by liquid chromatography triple quadrupole mass spectrometry and time-of-flight mass spectrometry. Rapid Communications in Mass Spectrometry. 2007; 21(4):614-18.

  34. Huang W, Wen K, Hsiao M. Adulteration by synthetic therapeutic substances of traditional Chinese medicines in Taiwan. Journal of Clinical Pharmacology. 1997;37(4):344-50.

  35. Ayad M, Abdellatef H, Hosny M, Kabil N. Utility of molybdophosphoric acid in qualitative and quantitative analysis of sibutramine HCl, sumatribtan succinate and lomefloxacine HCl. International Journal of Pharmaceutical and Biomedical Research. 2012; 3(2):121-26.

  36. Ayad M, Abdellatef H, Hosny M, Kabil N. Conductometric determination of sibutramine HCl, sumatriptan succinate and lomefloxacine HCl and the solubility products of their ion associates with molybdophosphoric acid. European Journal of Chemistry. 2013;4(3):297-302.

  37. Li Y, Hu J, Shi Y, Sun A, Sun C. Simultaneous determination of seven adulterants in slimming functional foods by HPLC-ESI-MS/MS. Food Analytical Methods. 2011;4(4):505-16.

  38. Bogusz M, Hassan H, Al-Enazi E, Ibrahim Z, Al-Tufail M. Application of LC-ESIMS- MS for detection of synthetic adulterants in herbal remedies. Journal of Pharmaceutical and Biomedical Analysis. 2006;41(2):554-64.

  39. Wang S, Yu J, Wan F, Ge S, Yan M, Zhang M. Determination of sibutramine with a new sensor based on luminol electrochemiluminescence. Journal of Luminescence. 2011;131(7):1515-19.

  40. Martini M, Machado L, Blasco A, Doménech A. Screening and authentication of herbal formulations based on microextraction-assisted voltammetry of microparticles. Anal. Methods. 2015;7:5740-5747.

  41. Rooney J, McDowell A, Strachan C, Gordon K. Evaluation of vibrational spectroscopic methods to identify and quantify multiple adulterants in herbal medicines. Talanta. 2015;138(1):77-85.

  42. Strano-Rossi S, Odoardi S, Castrignanòa E, Serpelloni G, Chiarott M. Liquid Chromatography-High Resolution Mass Spectrometry (LC-HRMS) determination of stimulants, anorectic drugs and phosphodiesterase 5 inhibitors (PDE5I) in food supplement. Journal of Pharmaceutical and Biomedical Analysis. 2015; 106:144- 152.

  43. Deconinck E, Custers D, De Beer. Identification of (antioxidative) plants in herbal pharmaceutical preparations and dietary supplements (Chapter 14). En: Donald Armstrong (eds). Advanced Protocols in Oxidative Stress III. Methods in Molecular Biology 1208. Ebook. New York: Humana Press; 2015. p.181-199.

  44. Da Silva L, Froehlich P, Bergold A. LC method for studies on the stability of sibutramine in soft gelatin capsules. Chromatographia. 2009;69 (2 Supl):109-13.

  45. Suthar A, Dubey S, Patel S. A validated specific reverse phase liquid chromatographic method for the estimation of sibutramine hydrochloride monohydrate in bulk drug and capsule dosage forms. International Journal of ChemTech Research. 2009;1(4):793-801.

  46. Mao H, Qi M., Zhou Y, Huang X, Zhang L, Jin Y, Penga Y, Du S. Discrimination of sibutramine and its analogues based on surface-enhanced Raman spectroscopy and chemometrics: toward the rapid detection of synthetic anorexic drugs in natural slimming products. RSC Advances. 2015; Issue 8:5886-94.




2020     |     www.medigraphic.com